Diabetes has been declared a global epidemic, the rapid rise in the number of people living with diabetes worldwide underscores the need for more effective treatments that can delay and even prevent the use of insulin injections. Researchers have been working for decades to try to develop an oral form of insulin that can be released through the digestive system, mimicking the body’s natural production of insulin. One company has achieved a scientific breakthrough in the oral delivery of proteins and is on track to be the first to bring an oral insulin capsule to market. Oramed Pharmaceuticals will soon be entering phase III trials for their oral insulin capsule and the company’s CEO Nadav Kidron joins remotely to discuss the revolutionary discovery and its implications in the treatment of diabetes.
